In a retrospective cohort study using propensity matching, among patients with obesity, those taking semaglutide had lower ...

Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...

Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...

Among 2,887 matched pairs, adults with obesity who received the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy) had a 26% lower risk of fracture than those who underwent sleeve gastrectomy ...

Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of semaglutide ...

Discover how semaglutide reduces heart attack and stroke risk by 20% in overweight individuals, with benefits appearing ...

The benefit was seen as soon as 3 months. Investigators say there should be no delaying treatment for eligible patients.

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or ...

Weekly 2.4 mg semaglutide was linked to improved liver histology results but did not significantly reduce body pain compared ...

Adults with mild autonomous cortisol secretion who undergo an adrenalectomy have a significantly reduced risk for vertebral fractures than those who do not have surgery, according to an analysis ...